Synthesis and Biological Evaluation of Honokiol Derivatives Bearing 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)oxazol-2(3H)-ones as Potential Viral Entry Inhibitors against SARS-CoV-2

• Main Authors: Yong Guo (Author), Jie-Ru Meng (Author), Jia-Zheng Liu (Author), Ting Xu (Author), Zhi-Yuan Zheng (Author), Zhi-Hong Jiang (Author), Li-Ping Bai (Author)
• Format: Book
• Published: MDPI AG, 2021-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The 2019 coronavirus disease (COVID-19) caused by SARS-CoV-2 virus infection has posed a serious danger to global health and the economy. However, SARS-CoV-2 medications that are specific and effective are still being developed. Honokiol is a bioactive component from <i>Magnoliae officinalis&l...